Preliminary Mapping of a Putative Inhibitor-binding Pocket for Human Immunodeficiency Virus Type 1 Integrase Inhibitors.
From: Department of Microbiology and Molecular Genetics, D440 Medical Sciences I, University of California, Irvine, California 92697-4800, USA. ewrobins@uci.edu
Antimicrobial agents and chemotherapy
- Publish Date: Jan 2006
- ISSN: 0066-4804
- Volume: 50
- Issue: 1
- Pages: 134-42
- Medium: Print
- Language: English
- Citation (JAMA): Lee Deborah J, Robinson W Edward, et al. Preliminary Mapping of a Putative Inhibitor-binding Pocket for Human Immunodeficiency Virus Type 1 Integrase Inhibitors.. Antimicrob. Agents Chemother. Jan 2006;50:134-42
Abstract
Molecular modeling studies have identified a putative human immunodeficiency virus (HIV) integrase (IN) inhibitor-binding pocket for l-chicoric acid (l-CA) and other inhibitors of IN (C. A. Sotriffer, H. Ni, and A. McCammon, J. Med. Chem. 43:4109-4117, 2000). By using site-directed mutagenesis of several amino acid residues identified by modeling studies, a common inhibitor-binding pocket on IN was confirmed for l-CA and the diketo acid L-731,988. Specifically, the single mutations E92K, Q148A, K156A, K156R, G140S, and G149S, as well as the double mutations C65S-K156N and H67D-G140A were evaluated for their effects on enzymatic activity and inhibitor susceptibility. Each recombinant IN was attenuated for 3’-end processing and strand transfer activities. Most proteins were also attenuated for disintegration; the IN that contained K156R and C65S-K156N, however, displayed disintegration activity similar to that of IN from HIV(NL4-3). All mutant IN proteins demonstrated decreased susceptibility to l-CA, while all mutant proteins except E92K and K156R demonstrated resistance to L-731,988. These data validate the computer modeling data and demonstrate that l-CA and L-731,988 share an overlapping inhibitor-binding pocket that involves amino acids Q148, C65, and H67. The resistance studies confirm that L-731,988 fills one-half of the inhibitor-binding pocket and binds to Q148 but excludes E92, while l-CA fills the entire binding groove and thus interacts with E92. These results provide “wet laboratory” evidence that molecular models of the HIV IN inhibitor-binding pocket can be used for drug discovery.
Mesh Headings (Keywords): Binding Sites, HIV Integrase, HIV Integrase Inhibitors, HIV-1, Humans, Models, Molecular, Recombination, Genetic
Check for Full Text / PubMed Unique Identifier (PMID): 16377678
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.